Akoya Biosciences (AKYA) IPO Opens 30% Higher

Today's IPO for Akoya Biosciences, Inc. (NASDAQ: AKYA) opened for trading at $26 after pricing 6,580,000 shares of its common stock at a price of $20.00 per share.

J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Piper Sandler &Co., and Canaccord Genuity LLC are acting as Joint Book-Running Managers for the offering.

As The Spatial Biology Company, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.

You May Also Be Interested In

• Karman Line Acquisition prices $200M IPO on Nasdaq
• Londian Wason New Energy Tech opens at $26, above IPO price of $22
• Libra Energy Materials options two Quebec lithium projects near Cisco